Company Data
Aprea Therapeutics Inc.
Ticker
APRE
Current Price
$1.83 5.78%
Market Cap
$10.1M
Price Target
Refer to Report
Volume
33.0K
52wk Range
$1.412 - $5.01
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).